Drugs / RO7122290
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04826003 | Jul 2021 → Nov 2024 | colorectal cancer | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7122290 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04826003 ↗ |